12.07.2015 Views

#06-5558 Accrd Manual V7 - COLA

#06-5558 Accrd Manual V7 - COLA

#06-5558 Accrd Manual V7 - COLA

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

CYTOLOGY740. EAre non-gynecologic specimens, with a high potential for cross-contamination, stained separately from othernon-gynecologic specimens and are the staining solutions filtered or changed after the staining?A monochrome stain such as toluidine blue may be used to determine the cellularity of non-gynecologicspecimens. Once the specimen has been concentrated, a drop of specimen can be stained and the cellularityevaluated microscopically. Highly cellular specimens have a high potential for cross-contamination. Oneoption would be for the laboratory to stain these specimens after routine staining has been completed.741. EAre the stained slides reviewed daily for the expected staining characteristics?The cytology laboratory must ensure that gynecologic and non-gynecologic stains have been tested toensure predictable staining characteristics on a daily basis.742. EDoes the cytology laboratory document all control procedures on a daily basis?The cytology laboratory must document all control procedures including slide staining reactions, expirationdates of stocks, reagents, working stains and solutions made in the laboratory. Measurements, reactions,and/or observations that demonstrate that controls were tested prior to use must be recorded.The laboratory shall have written workload policies for individuals (including cytotechnologists and pathologists)who perform primary screening.743. EHas laboratory management established cytology workload limits in compliance with local, regional andnational regulations?> NOTE: The following criteria for workload limits are CLIA requirements.744. EAre the workload limits for each individual who performs primary screening established by the TechnicalSupervisor?Are the workload limits based on each screener’s documented performance using:745. E10% of the screener’s cases reported as negative?746. EA comparison with the technical supervisor’s confirmation of patient smears for abnormalities found at 783-792?86. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .FOR MORE INFORMATION CONTACT <strong>COLA</strong> PHONE 800.981.9883 | FAX 410.381.8611 | ON-LINE www.cola.org

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!